Author pages are created from data sourced from our academic publisher partnerships and public sources.
Minireview: Malassezia infections in immunocompromised patients.
Malassezia spp. form part of the normal human cutaneous flora and are implicated in several mild, but recurrent cutaneous diseases, such as pityriasis versicolor, Malassezia folliculitis, seborrhoeic… Expand
Invasive aspergillosis in children with acquired immunodeficiencies.
- A. Tragiannidis, E. Roilides, T. Walsh, A. Groll
- Clinical infectious diseases : an official…
- 15 January 2012
Invasive aspergillosis has emerged as an important cause of morbidity and mortality in immunocompromised children. It remains difficult to diagnose, and outcome depends on early diagnosis,… Expand
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Introduction: Invasive candidiasis (IC), mainly candidemia, is a leading cause of morbidity and mortality among immunocompromised patients and those admitted to intensive care units. Despite the… Expand
Recent advances in antifungal prevention and treatment.
Invasive fungal infections are important causes of morbidity and mortality in patients with bone marrow failure syndromes and hematological malignancies, or who are undergoing allogeneic… Expand
Antifungal Chemoprophylaxis in Children and Adolescents with Haematological Malignancies and Following Allogeneic Haematopoietic Stem Cell Transplantation
Invasive opportunistic fungal infections are important causes of morbidity and mortality in children and adolescents with cancer or haematopoietic stem cell transplantation (HSCT). Difficulties in… Expand
Clinical hepatotoxicity associated with antifungal agents
- Ioannis Kyriakidis, A. Tragiannidis, Silke Munchen, A. Groll
- Expert opinion on drug safety
- 16 December 2016
ABSTRACT Introduction: Invasive fungal diseases (IFDs) are a leading cause of morbidity and mortality among immunocompromised patients with bone marrow failure syndromes, hematological malignancies,… Expand
Standard-dose Intravenous Anti-D Immunoglobulin Versus Intravenous Immunoglobulin in the Treatment of Newly Diagnosed Childhood Primary Immune Thrombocytopenia
- Andromachi Papagianni, M. Economou, +5 authors M. Athanasiou-Metaxa
- Journal of pediatric hematology/oncology
- 1 May 2011
Background We conducted a study to evaluate the efficacy of intravenous (IV) anti-D against IV immunoglobulin (IVIG) in newly diagnosed immune thrombocytopenia (ITP) in children and to identify the… Expand
Invasive aspergillosis in children and adolescents.
- A. Groll, D. Schrey, A. Tragiannidis, K. Bochennek, T. Lehrnbecher
- Current pharmaceutical design
- 31 May 2013
Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised children. Disease control depends on prevention, early diagnosis, predictive microbiological information,… Expand
Burden of rotavirus gastroenteritis in children <5 years of age in Greece: hospital-based prospective surveillance (2008–2010)
Objectives This study describes the epidemiology of rotavirus (RV) gastroenteritis (GE) disease following the introduction of RV vaccination in Greece in 2006. Design A prospective hospital-based… Expand
Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.
Invasive candidiasis (IC) and candidaemia are leading causes of infectious morbidity and mortality among immunocompromised paediatric patients and those admitted to intensive care units. Despite… Expand